1

Curriculum Vita Personal Specifications:

Name: Sadeq Vallian-Broojeni (Vallian)

Date of Birth: 22nd November, 1965

Sex: Male

Marital Status: Married

Address:

Work: Division of Genetics, Department of Biology, Faculty of Science, University of Isfahan, Hezarjerib St., Isfahan, IR Iran.

Tel: + 98 31-3793 2462 (Direct) +98 31-37932455 (secretary) Fax: +98 31-37932456

Email: svallian@sci.ui.ac.ir, sadeqvallian@gmail.com

Academic Qualifications:

1. Ph.D. (1992-1996) in Medical Molecular Genetics: Department of Molecular Medicine, King’s College School of Medicine and

Dentistry, King’s College London, University of London, U.K.

2. M.Sc. (1988-1991) in Biochemistry: Division of Biochemistry, School of Pharmacy, Isfahan Medical University, Isfahan, Iran.

3. B.Sc. (1984-1988) in Genetics: Division of Biology, Faculty of Science, Ahwaz University, Ahwaz, Iran.

Employment and Experience:

1. Professor of Human Molecular Genetics, 2013 to date, University of Isfahan.

2. Associate professor in Human Molecular Genetics (2005- 2012), University of Isfahan.

3. Assistant professor in Human Molecular Genetics (1999 - 2005), University of Isfahan.

4. Postdoctoral Fellowship (1997-1999), Division of Laboratory Medicine, Box 72, The University of Texas M.D. Anderson Cancer

Center, Houston, Texas 77030, U.S.A.

2

Membership in Organizations:

1. European society of human genetics, Membership #3878

2. International Federation of Human Genetics Societies

3. The Iranian Biological Society (academic member).

4. The American Association for Cancer Research (AACR), associate member (Membership # 18247).

5. The American Society for Cell Biology (ASCB)

6. Iranian Society of Human Genetics (academic member).

7. Iranian Society of Biotechnology (academic member).

Scholarships and Awards:

1. Distinguished professor of University of Isfahan, 2008

2. Yang scientist and travel award to attend the HOPO 2nd

Annual & IOBMB XIX world congress October 8-11, 2003, Montreal,

Canada.

3. Travel award to attend the 10th

International Congress of Human Genetics, 15-19 May, 2001, Austria Center Vienna, Austria.

4. Travel award to attend the workshop on the Integration of Transcriptional Regulation and Chromatin Structure, 10-12 April, 2000,

Institute Juan March, Madrid.

5. First Place Amgen Award in Basic Research (International), presented by MD Anderson Associates, University of Texas, USA, May

29, 1998.

6. Travel award to attend the 39th Annual Meeting of the American Society of Hematology, San Diego, California, December, USA, 5-

9, 1997 (funded by the American Society of Hematology).

7. Travel award to attend the M.D. Anderson Symposium on Genetics Mechanisms of Cancer, Houston, Texas, USA, 17-20, October,

1995 (this award covered the expenses from London to Houston, and was funded by M.D. Anderson cancer center, Houston, Texas,

USA).

8. Scholarship from the Ministry of Culture and Higher Education, Iran, for a Ph.D degree in Molecular and Cellular Biology at the

University of London, 1992-1996.

9. Scholarship from the Ministry of Health, Treatment and Medical Education, Iran, for an M.Sc degree in Biochemistry at Isfahan

Medical University, 1988-1991.

3

Publications

A) Research Articles (Peer reviewed)

1. Mohamadi Farsani F, Ganjalikhany MR and Vallian S (2016) Studies on non-synonymous polymorphisms altering human DNA

Topoisomerase II-alpha interaction with Amsacrine and Mitoxantrone: An in silico approach. Current Cancer Drug Targets (in press).

2. Mohamadi Farsani F, Ganjalikhany MR, Dehbashi M, Mojtabavi Naeini M and Vallian S (2016) Structural basis of DNA

topoisomerase II-α (Top2-α) inhibition: a computational analysis of interactions between Top2-α and its inhibitors. Medicinal

Chemistry Research, 25, 6 (125-1259).

3. Saamaaneh Soheili, Sadeq Vallian Borujeni (2015) Genotyping Analysis of rs1799989 Single Nucleotide Polymorphism in TYR Gene

Region in the Population of Isfahan, Iran. Journal of Kerman University of Medical Sciences, 22(5): 484-490 (Farsi).

4. Maryam Sedghi, Sadeq Vallian (2015) D5S351 and D5S1414 located at the spinal muscular atrophy critical region represent novel

informative markers in the Iranian population. Meta Gene 7: 16–19.

5. Taherh Moradi, Reihaneh Vallian, Zahra Fazeli, Asieh Haghighatnia, Sadeq Vallian (2015) Heterozygosis deficient of polymorphic

markers linked to the beta-globin gene cluster region in the Iranian population. Iranian Journal of Basic Medical Sciences, 18:571-575.

6. Mahsa Shirani, Sadeq Vallian (2015) DXS998–DXS548–FRAXAC1 represents a novel informative haplotype at the FMR1 locus in the

Iranian population. Gene, 570: 180–184.

7. Dorri P, Karimi A, Vallian-Borujeni S (2014) Genetic variation of rs438601 marker in the Iranian Population: An informative marker for

molecular diagnosis of hemophilia B. Journal of Shahid Sadoughi University of Medical Sciences, 22(5), 1524-1532 (Farsi).

8. Seyed Morteza Javadirad1, and Sadeq Vallian (2014) Phylogenic Analysis of Cellular Life Forms Using U5 Snrnp Components. Journal

of Applied Bioinformatics and Computational Biology, 3:1-3.

9. Mehraban MH 1, Jamshidi J2, Vallian Sadeq (2014) Gene Families: Structure, Organization and Evolution. Journal of Fasa

University of Medical Sciences, 4 (2), 143-153 (Farsi).

10. Mojtabavi Naeini Marjan, Mesrian Tanha Hamzeh, Emamzadeh Rahman, Vallian Sadeq (2014) A computational prospect to aspirin

side effects: Aspirin and COX-1 interaction analysis based on non-synonymous SNPs. Computational Biology and Chemistry, 51,

57–62.

11. Sedigheh Givi and Sadeq Vallian (2014) Ava II-Taq I-Hind III represents a novel informative haplotype at the β-globin gene cluster:

Application in carrier detection and prenatal diagnosis of beta Thalassemia in the Iranian population. . Annals of Experimental

Biology, 2 (1):53-57.

12. Amin Karimi و Sadeq Vallian (2014) Analysis of Genetic Variation of rs11658369 Marker in AIPL1 Gene as an Informative Marker

for Molecular Diagnosis of Leber Congenital Amaurosis (LCA) in Isfahan Population. Genetics in the Third Millennium, 11(4),

20-29 (Farsi).

4

13. Morteza Sadeghi1 and Sadeq Vallian (2013) The Closest of Human between Three Hominidae Based on 16S rRNA Sequence

Homology. International journal of Evolution, 2:1-3.

14. Marjan Mojtabavi Naeini, Sadeq Vallian Boroujeni and Morteza Hashemzadeh Chaleshtori (2013) Study of Alleles Characteristics

and Informativeness of D7S2459 Marker in Five Ethnic Groups of the Iranian Population (2013) Arak Medical University Journal

(AMUJ), 16(76): 55-65 (Farsi).

15. Fariba Dehghanian and Sadeq Vallian Boroujeni (2013) Steroid receptors and miRNA. Genetics in the Third Millennium, 10(4),

78-85 (Farsi).

16. Marjan Mojtabavi Naeini, Sadeq Vallian Boroujeni and Morteza Hashemzadeh Chaleshtori (2013) Genetic variation of D7S2420

marker in five ethnic groups of the Iranian population: a highly informative marker for molecular diagnosis of ARNSHL. Genetics in

the Third Millennium, 11 (1), 2960-2969 (Farsi).

17. Maryam Shaykholeslam Esfahani, Sadeq Vallian (2013) Characterization and specification of microsatellite markers in the HLA-

DRB1 gene region: A revision to major histocompatibility complex database. Human Immunology 74:965–969.

18. Halimeh Rezaei, Zahra Fazeli Attar, Marjan Mojtabavi Naeini and Sadeq Vallian Boroujeni (2013) Conservation of polymorphism in

GJB2 gene markers in Iranian population by balancing selection. Taxonomy and Biosystematics, 5(14):35-40 (ISC)

19. Morteza Sadeghi and Sadeq Vallian (2013) The closest of human between three Hominidae based on 16S rRNA sequence homology.

Int J Evol, 2:1-3.

20. Zahra Fazeli Sadeq Vallian (2013) Molecular phylogenetic study of the Iranians based on polymorphic markers. Gene, 512: 123–126.

21. Fariba Dehghanian and Sadeq Vallian (2012) Relationship between Steroid Receptors and microRNA. Genetics in the 3rd

millennium, 10(4): 2932-240.(ISC)

22. Zahra Fazeli Sadeq Vallian (2012) Phylogenetic relationship analysis of Iranians and other world populations using allele frequencies

at 12 polymorphic markers. Mol Biol Rep, 39:11187–11199.

23. Haghighatnia Asieh, Vallian Sadeq, Mowla Javad, Fazeli Zahra (2012) Genetic diversity and balancing selection within the human

PAH gene region in the Iranian population. Iranian J of Public Health, 41, 5,97-104.

5

24. Sadeq Vallian, Moreteza Javadi Rad, Mahmood Tavallaei, Manoochehr Tavassoli. (2012) Correlation of major histocompatibility

complex class I related A (MICA) polymorphism with the risk of developing breast cancer. Medical Oncology, 29,1,5-9. (IF 1.356)

25. Ghoochani A, Shabani K, Peymani M, Ghaedi K, Karamali F, Karbalaei K, Tanhaie S, Salamian A, Esmaeili A, Valian-Borujeni S,

Hashemi M, Nasr-Esfahani MH, Baharvand H. (2012) The influence of peroxisome proliferator-activated receptor γ(1) during

differentiation of mouse embryonic stem cells to neural cells. Differentiation, 83(1):60-7 (IF 2.98)

26. Mansoureh Tajadod , Zahra Fazeli, Sadeq Vallian (2011) Population data on D6S2879 and D6S2806 markers located at HLA-DRB1

region in the Iranians: Identifying the signatures of balancing and directional selection. Taxonomy and Biosystematics (Isfahan

university), 8:51-60 (ISC) (in English).

27. Sadeq Vallian, Zahra Fazeli (2011) Phenyketonuria from genetics to clinics: an Iranian Prospect. Iranian J Biotechnology,9,3,163-

172. (ISI, ISC)

28. Shaykholeslam M, Vallian S. (2011) Analysis of specificity of M2-236 marker for geneotyping HLA-DRB1: an update to

dbMHC. Tissue Antigen,78, 1, 8–10. (IF 2.33)

29. Rezaei, H., Vallian, S. (2011) BanI/D13S141/D13S175 Represents a Novel Informative Haplotype at the GJB2 Gene Region in the

Iranian Population. Cell and Molecular Neurobiology. 749-754. (IF 2.1)

30. Fazeli Zahra, Vallian Sadeq (2011) An artifact band frequently associated with variable number of tandem repeat (VNTR) marker at

phenylalanine hydroxylase (PAH) gene: application in carrier detection and prenatal diagnosis of Phenylketonuria. Molecular

Biology Reports, 38:3395–3399. (IF 2.038)

31. Vallian Sadeq, Nassiri Isar, Tavassoli Manoochehr (2010) Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter

hypermethylation. Medical Oncology, (published online, 17 March, 2010). (DOI 10.1007/s12032-010-9473-8) (IF 1.356)

32. Vallian S, M. Tajadod & Z. Hojati, (2010). Characterization of D6S2806 and D6S2879 short tandem repeat loci in HLA-DRB1

region in Iranian population. Tissue Antigen, 76, 60-63. (IF 2.33)

6

33. Sadeq Vallian and Issar Nassiri (2010) Development of a Sensitive Deaminated Single-Strand Conformation Polymorphism

(DSSCP). Applied Biochemistry and Biotechnology, 160, 3, 927-31. (IF 1.64)

34. Rezaei, H., Vallian, S., Rezvan Movahedi. (2010) High frequency of 35delG mutation in GJB2 associated with autosomal recessive

nonsyndromic hearing loss (ARNSHL) in the province of Isfahan-Iran. Genetics in the 3rd millennium, 8(3): 2074-2078. (ISC)

35. Alireza Moafi, Sadeg Valian, Zahra Nikyar, Mehrdad Zeinalian, Maryam Momenzadeh, Soheila Rahgozar. (2010) Prevalence of

Minor β-thalassemia Based on RBC Indices among Final Suspected Individuals in Premarital Screening Program Referred to Genetic

Laboratories. International Journal of Hematology Oncology and Stem Cell Research (IJHOSCR), 23-27.

36. Fazeli Zahra, Vallian Sadeq, Haghighatnia Asieh, Mola Javad (2009) Haplotype analysis of PvuII(a)-MspI-VNTR markers in PAH

gene in Iranian population. Genetics in the third Millennium, 1483-1477. (ISC)

37. Mohammad Ronaghi, Sadeq Vallian, Masoud Etemadifar (2009). CD24 gene polymorphism is associated with the disease

progression and susceptibility to multiple sclerosis in the Iranian population. Psychiatry Research, 170, 2, 271-272. (IF 2.298)

38. Sadeq Vallian, Mandana Sedaghat, Issar Nassiri, Ali Farazmand (2009) Methylation status of p16INK4A promoter in Ifranian

patients with breast cancer. J Cancer Res Clin Oncol, 135(8):991-6. (IF 2.366)

39. Zahra Fazeli and Sadeq Vallian (2009). Estimation Haplotype Frequency of BglII/EcoRI/VNTR markers at the PAH Gene Region in

Iranian Population. International Journal of Human Genetics, 9(2): 115-121. (ISI)

40. Vallian S and Seilani MR (2009) Quantitative Bacterial Micro-Assay for RapidDiagnosis of Galactosemia: Application in

Galactosemia Neonatal Screening. Journal of Sciences, Islamic Republic of Iran, 20(4): 319-323. (ISI)

41. Z Fazeli, S Vallian (2009) The Investigation of Haplotype Phasing Efficiency at the PAH Gene Region in Iranian Family Trios,

Iranian J Publ Health, 38,4, 136-139. (ISI/ISC)

42. Fazeli Z, Vallian S (2009) Evidences for balancing selection from PAH-BglII and PAH-EcoRI polymorphisms in Isfahan population.

Taxonomy and Biosystematics (University of Isfahan), 1, 73-80.(ISC)

7

43. Vallian S and Nassiri I. (2008) Molecular bases and diagnosis of Charcot-Marie-Tooth. Tashkhis Azmayeshgahi, 56: 34-42.

(Domestic, Farsi)

44. Sadeq Vallian and Mohmmad Reza Khazaei (2007) Aptamers in nanomedicine. Research in Pharmaceutical Sciences, 2(2): 59-66.

(ISC)

45. Abedi D, Jahanian A, Sadeghi MH, Vallian S. (2007) Cloning and partial sequencing of phac1 and phac2 genes encoding poly (3-

hydroxyalkanoate) synthesis from pseudomonas aeroginusa PTCC1310. Biotechnology, 6(4), 497-504. (ISI)

46. Vallian S and Moeini M. (2006) Genotyping of five polymorphic STR loci in Iranian province of Isfahan. Journal of Science, IRI,

17(2):113-117. (International, ISI).

47. Vallian S and Moeini M. (2006) Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots:

application in phenylketonuria screening. Clin. Chem. Lab. Med., 44(1):76-79. (IF 1.741)

48. Saeidi H., Rahiminejad M.R., Vallian S. and Heslop-Harrison J.S. (2006) Biodiversity of diploid D-genome Aegilops tauschii coss in

Iran measured using microsatellites. Genetic Resources and Crop Evaluation, 53:1477-1484.

49. Moeini H, Vallian S, Nahvi N, Behzadipoor N (2006) Isolation of a mutatnt of Kluyveromyces marxianus resistant to glucose

repression. Pakistan J Biological Sciences, 9,1, 115-118. (ISI)

50. Vallian S. and Chang K-S. (2005) Specific inhibition of the expression of the promyelocytic leukemia, PML, protein by anti-sense

oligonucleotides. Iranian J of Biotechnology, 3(2):94-98. (International, ISI).

51. Vallian S., Khazaei MR and Karimzadeh F. (2005) A new enzymatic method for rapid diagnosis of phenylketonuria using

Alkaliphilic Bacillus. Journal of Sciences IRI, 16(3):233-237. (International, ISI)

52. Vallian S. and Barahimi E. (2005). Application of the PAHVNTR marker in PKU carrier diagnosis in Isfahan. Genetics in the Third

Millennium, 3(3):572-576.(Persian) (ISC).

53. Madani H., Vallian S. and Naghsh N. (2005). Analysis of contrasting effects of Alloxan and magnesium on plasma fatty acids (FFA)

in diabetes induced rats. Iranian Journal of Diabetes and Lipid Disorders, 4(2):1-5. (Persian).

8

54. Vallian S (2005) Prenatal diagnosis of genetic diseases. Tashkhis Azmaieshgahi, 37:10-15. (Persian).

55. Vallian S and Salehi Z. (2007) Nanobiotechnology and its application in diagnosis of genetic diseases. Modern Genetics Journal,

2(4):5-14. (ISC)(Domestic, Farsi)

56. Vallian S. (2004). The promyelocytic leukemia protein, PML, and its biological function. Iranian J of Biotechnology, 2(4):220-229.

(International, ISI)

57. Moeini H., Vallian S. and Nahvi I. (2004). Isolation and identification of yeast strains capable of producing single cell protein from

whey in co-cultures with saccharomysis cerevicia. Iranian J Biotechnology, 2, 1, 13-18. (International, ISI)

58. Vallian S. and K-S Chang (2004). Down regulation of DHFR promoter activity by PML transcription repressor. Iranian Journal of

Science IRI, 15, 3, 1016-1104. (International, ISI)

59. Vallian S. and K-S Chang (2004). Expression of PML tumor suppressor in A431 cells reduces cellular growth by inhibiting the

EGFR expression. Iranian Journal of Science and Technology, Transaction A, Vol. 28, No. A1. (International, ISI)

60. Bouzari M, Vallian S, Ghalamkari HR and Moeini H. (2004). Sex determination in bovine by PCR technique. Research Journal of

Isfahan University (Science), 19, 1, 99-112. (Persian)

61. Vallian S, Madani H and Naghsh N. (2004) Analysis of changes in plasma and red blood cells Magnesium in Diabetes induced by

Alloxan in Rat. Research Journal of Isfahan University (Science), 19, 1, 53-60. (Persian)

62. Madani S., Ehsanpoor A.A. and Vallian S. (2004). The study of variation in long-term cultured potato shoot tips in mannitol using

RAPD-PCR. Journal of Science of University Tehran, 30, 459-506. (Persian).

63. Madani H, Vallian S, and Naghsh N. (2004). Investigation of changes in amount of plasma lipids and lipoproteins and intracellular

magnesium in Diabetic Rats. Research Journal of Isfahan University (Science), 19, 1, 71-78. (Persian)

64. Vallian S. and Farzaneh F. (2003). Expression of recombinant 3-bet hydroxysteroid dehydrogenase protein in E. coli. The Iranian J

of Biotechnology, 1, 2, 109-114. (International, ISI)

9

65. Vallian S., Barahimi E, Moeini H. (2003). Phyenylketonuria in Iranian population: a study in Institutions for mentally retarded in

Isfahan. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 526, 45-52. (IF 3.76)

66. Vallian S. (2003). Expression of recombinant PML protein under the inducible viral T5 promoter. Research Journal of Isfahan

University (Science), 17, 1, 103-120. (Persian)

67. Wu W-S, Sadeq Vallian, Seto E., Yang W-M, Edmondson D., Roth S., and Chang K-S (2001). The growth suppressor PML

Represses Transcription by functionally and physically interacting with histone deacetylases. Molecular and Cellular Biology, 21

(7), 2259-2268. (The first two authors contributed equally and considered as first author, as in acknowledgments) (IF 6.77)

68. Vallian S., Chin K-V, and Chang K-S (1998). The promyelocytic leukemia protein interacts with Sp1 and inhibits Sp1-mediated

transcription of the epidermal growth factor receptor (EGFR) promoter. Molecular and Cellular Biology, 18(12), 7147-56. (IF 6.77)

69. Vallian S., Gaken J,. Gingold E. B., Kouzarides T., Chang K-S, Farzaneh F. (1998). Regulation of Fos-mediated AP-1 transcription

by the promyelocytic leukemia protein. Oncogene 16, 2843-2853. (IF 6.58)

70. Le X-F, Vallian S., Mu Z-M, Hung M-C and K-S Chang (1998). Recombinant PML adenovirus suppresses growth and tumorigenisity

of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16, 1839-1849. (IF 6.58)

71. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH (1998). Collagen type VI gene expression in the

skin of trisomy 21 fetuses. Obstetrics and Gynecology, 91(3):319-23. (IF 4.39)

72. Vallian S.,. Gaken J A, Ian D. Trayner, Gingold E. B., Kouzarides T., Chang K-S, Farzaneh F. (1997). Transcriptional repression by

the promyelocytic leukemia protein, PML. Experimental Cell Research, 237, 371-382. (IF 3.78)

73. Mu Z-M, Le X-F, Vallian S.,. Glassman A. B., K-S Chang (1997). Stable overexpression of PML alters regulation of cell cycle

progression in HeLa cells. Carcinogenesis, 18 (11), pp. 2063-2069. (IF 4.79)

74. Arif S., Vallian S., Farzaneh F.,. Zanone M. M., James S. L., Pietropaolo M., Hettiarachi S., Vergani D., Conway G. S, Peakman M.

(1996). Identification of 3 -Hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of

10

autoantibodies with endocrine autoimmune Disease. Journal Clinical Endocrinology and Metabolism, 81 (12), pp. 4439-4445. (IF

6.2)

75. . Gaken J. A, Tavassoli M., Gan S-U, Vallian S., Giddings I., Darling D., Galea-Lauri J., Thomas M. G., Abedi H., Schreiber V.,.

Muricia J. M.,. Collins M. K. L, Shall S., Farzaneh F. (1996). Efficient retroviral infection of mammalian cells is blocked by

inhibition of poly (ADP-Ribose) polymerase activity. Journal of Virology, 70 (6), pp.3992-4000. (IF 5.33)

76. Kun-Sang Chang, Xiao-Feng Le, Dalin He, Zhao-Mei Mu, Sadeq Vallian, J.T. Hsieh, L.W.K. Chung. (1997) Recombinant PML

adenovirus as a potential tool for cancer gene therapy. Anticancer Research, 17, pp. 3986-3987. (IF 1.41)

77. Ani M, Moshtaghi A A., Vallian S (1996). Changes in the plasma levels of lipid fractions and lipoprotein lipase activity following

aluminum administration. Clinical Chememistry and Enzyme Comms., 7, pp. 81-92.

78. Vallain S. Characterization of transcriptional regulatory function of human acute promyelocytic leukemia proteins, PML and

PMLRAR. PhD Thesis (December, 1995). University of London, Senate House, Malet St., London WC1E 7HU.

79. Vallian S. Analysis of the effects of Aluminum on liver and plasma lipid metabolism. MSc. Thesis (August, 1991). School of

Pharmacy, Isfahan Medical University, Isfahan, Iran.

11

خاتمه یافته طرح های پژوهشی

فيدر

عىان گسارش محل اوجبم

فعبليت

تبريخ اوجبم

پبيبن ضرع

بررسي مبركراب نوييياي وبهيا نن 1

فىيل آالويه يدركسيالز

داوطگبي

اصفبن

1385 1387

كلويىگ ارزيببي عمليارد سابايبر 2

cDNA نن پرتئيه پراكسيسمي مش

داوطگبي

اصفبن

1385 1387

STRبررسی تىع نوتيپی وطابوگرب 3

در اصفبن

داوطگبي

اصفبن

1382 1385

RNAiسبات کبربرد ريسملکل اب 4

در مبر اايصبصی بيبن نن

داوطگبي

اصفبن

1386 1389

در جمعيات 35delGيررسي فرااوي جص 5

اصفبن

گبي داوط

اصفبن

1391 1391

12

تالیفات

1

مباوي ملكلي ژوتيك

اوساوي

▀

داوشگا

ي

اصفان

صادق 7831

-ليان

ایثار

-وصيری

محمدرضا

خساعی

گردآری

تاليف

2

Concepts of Genetics /

مفايم ژوتيك

اوتشار

ات ور

)تران

)

7831

صادق ليان

برجىي/

ایثار

وصيري/

فاطم

ابرايمي/

ریحاو

لحمي

ترجم

3

مقدم اي برر مىديري

ژوتيك

داوشگا

ي

اصفان7831

صادق ليان

-برجىي

محمد روقي

ترجم

4 جمعيتژوتيك

داوشگا

ي

اصفان7831

صادق

زرا -ليان

فاضلي

تدیه

5 ييتژوتيك

داوشگا

ي

اصفان

صادق

زرا -ليان

فاضلي

در ديت

برريی

6 تكامل

داوشگا

ي

اصفان

ق ليان صاد

برجىي

در ديت

برريي

13

Academic referees

1. Dr. Farzin Farzaneh

Professor of Molecular Medicine and Head of Department

Department of Molecular Medicine, King’s College School of Medicine and Dentistry, The Rayne Institute, 123 Coldharboure

lane, London SE5 9NU, U.K.

Tel: UK 171 346 3126

Fax: UK 171 733 3877

Email: f.farzaneh@kcl.ac.uk

2. Dr. Kun-Sang Chang

Professor

Dept. of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 89, Houston,

Texas, USA 77030. Tel.: 713-792-2581; Fax: 713-794-4672; E-mail: kchang@mail.mdanderson.org.

3. Dr. Joop Gaken

Senior Lecturer in Molecular Genetics

Department of Molecular Medicine, King’s College School of Medicine and Dentistry, The Rayne Institute, 123 Coldharboure

lane, London SE5 9NU, UK.

Tel: UK 171 346 3126

Fax: UK 171 733 3877

Email: jgaken@hgmp.mrc.ac.uk